11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene

Preferred Label : 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene;

MeSH note : for treating lymphoma and myelofibrosis; structure in first source;

MeSH hyponym : SB1518; SB-1518;

Is substance : O;

Détails

Origin ID

C561234;

UMLS CUI

C3254376;

Automatic exact mappings (from CISMeF team)
- Pacritinib [NCIt concept]
MeSH indexing information
- fms-like tyrosine kinase 3 [MeSH Descriptor]
- janus kinase 2 [MeSH Descriptor]
MeSH term(s) associated for indexing
- Bridged-Ring Compounds [MeSH Descriptor]
- pyrimidines [MeSH Descriptor]
Record concept(s)
- 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene [MeSH concept]
- SB 1518 [MeSH concept]
- pacritinib [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients